Interhemispheric differences of pyramidal cells in the primary motor cortices of schizophrenia patients investigated postmortem

Cereb Cortex. 2023 Jun 20;33(13):8179-8193. doi: 10.1093/cercor/bhad107.

Abstract

Motor disturbances are observed in schizophrenia patients, but the neuroanatomical background is unknown. Our aim was to investigate the pyramidal cells of the primary motor cortex (BA 4) in both hemispheres of postmortem control and schizophrenia subjects-8 subjects in each group-with 2.5-5.5 h postmortem interval. The density and size of the Sternberger monoclonal incorporated antibody 32 (SMI32)-immunostained pyramidal cells in layer 3 and 5 showed no change; however, the proportion of larger pyramidal cells is decreased in layer 5. Giant pyramidal neurons (Betz cells) were investigated distinctively with SMI32- and parvalbumin (PV) immunostainings. In the right hemisphere of schizophrenia subjects, the density of Betz cells was decreased and their PV-immunopositive perisomatic input showed impairment. Part of the Betz cells contained PV in both groups, but the proportion of PV-positive cells has declined with age. The rat model of antipsychotic treatment with haloperidol and olanzapine showed no differences in size and density of SMI32-immunopositive pyramidal cells. Our results suggest that motor impairment of schizophrenia patients may have a morphological basis involving the Betz cells in the right hemisphere. These alterations can have neurodevelopmental and neurodegenerative explanations, but antipsychotic treatment does not explain them.

Keywords: antipsychotics; human brain; immunohistochemistry; neuropathology; parvalbumin.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aging
  • Animals
  • Antipsychotic Agents / therapeutic use
  • Autopsy
  • Datasets as Topic
  • Disease Models, Animal
  • Female
  • Functional Laterality* / drug effects
  • Haloperidol / pharmacology
  • Haloperidol / therapeutic use
  • Humans
  • Immunohistochemistry
  • Intermediate Filaments / metabolism
  • Male
  • Middle Aged
  • Motor Cortex* / drug effects
  • Motor Cortex* / pathology
  • Olanzapine / pharmacology
  • Olanzapine / therapeutic use
  • Parvalbumins / metabolism
  • Pyramidal Cells* / drug effects
  • Pyramidal Cells* / pathology
  • Rats
  • Rats, Sprague-Dawley
  • Regression Analysis
  • Schizophrenia* / drug therapy
  • Schizophrenia* / pathology

Substances

  • Antipsychotic Agents
  • Haloperidol
  • Olanzapine
  • Parvalbumins